Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 52
Filtrar
1.
Med. infant ; 30(2): 198-203, Junio 2023.
Artigo em Espanhol | LILACS, UNISALUD, BINACIS | ID: biblio-1443803

RESUMO

A lo largo de la historia, el rol del bioquímico en el laboratorio clínico ha ido mutando, adaptándose a nuevos paradigmas, consecuencia del avance de la tecnología1 y la informática, de la presión externa ejercida por las empresas proveedoras de reactivos que reducen el tiempo útil de los equipos, aumentando su tasa de recambio, de una medicina más compleja que impone nuevos desafíos diagnósticos y de los cambios sociales que se ven reflejados en una alteración en el orden de los valores adoptado por las nuevas generaciones de profesionales que conviven con otras, provocando "turbulencia generacional" en los lugares de trabajo. Los laboratorios necesitan hoy someterse a una reingeniería de sus procesos, descartar aquellos que no agreguen valor, que causan fugas innecesarias de insumos, personas y tiempo e intervenir la cultura organizacional de manera integral, para adaptarse a las exigencias que la actualidad requiere, donde la calidad, la seguridad y la sostenibilidad son los principales protagonistas )AU)


Over time, the role of the biochemist in the clinical laboratory has been changing, adapting to new paradigms, as a consequence of the advance of technology and informatics, of the external pressure exerted by the companies supplying reagents that reduce the useful time of the equipment, increasing its replacement rate, of a more complex medicine that imposes new diagnostic challenges, and of social changes that are reflected in an alteration in the values adopted by the new generations of professionals who coexist with others, causing "generational turbulence" in the workplace. Laboratories today need to reengineer their processes, eliminate those that do not add value, that cause unnecessary waste of supplies, people and time, and intervene in the organizational culture in a comprehensive manner, in order to adapt to the demands of today's world, where quality, safety, and sustainability are the main drivers (AU)


Assuntos
Humanos , Laboratórios Hospitalares/tendências , Pessoal de Laboratório Médico/tendências , Papel Profissional , Serviços de Laboratório Clínico/tendências , Gestão da Qualidade Total
2.
Fertil Steril ; 116(1): 13-14, 2021 07.
Artigo em Inglês | MEDLINE | ID: mdl-34148581

RESUMO

The goal of this Views and Interviews series was to bring together the thought leaders in the field and envision what the laboratory will look like in the future. This consensus piece strives to take the thoughts of those leaders and develop themes and concepts that will be significant in the laboratory in the coming years.


Assuntos
Andrologia/tendências , Inteligência Artificial/tendências , Serviços de Laboratório Clínico/tendências , Fertilização in vitro/tendências , Infertilidade/terapia , Medicina Reprodutiva/tendências , Automação Laboratorial , Consenso , Difusão de Inovações , Feminino , Previsões , História do Século XXI , Humanos , Infertilidade/diagnóstico , Infertilidade/fisiopatologia , Masculino , Gravidez
3.
Fertil Steril ; 116(1): 2-3, 2021 07.
Artigo em Inglês | MEDLINE | ID: mdl-34148585

RESUMO

The in vitro fertilization and andrology laboratories are at the center of assisted reproductive technologies and the place where technicians and embryologists manipulate gametes and preimplantation-stage embryos with the goal of achieving the best embryo for transfer. Through the years, these laboratories have seen developments in technique, technology, and testing. The goal of this Views and Interviews series is to bring together the thought leaders in the field and envision what the laboratories will look like in the next 10 years.


Assuntos
Andrologia/tendências , Serviços de Laboratório Clínico/tendências , Fertilização in vitro/tendências , Infertilidade/terapia , Medicina Reprodutiva/tendências , Difusão de Inovações , Feminino , Previsões , História do Século XXI , Humanos , Infertilidade/diagnóstico , Infertilidade/fisiopatologia , Masculino , Gravidez
4.
Fertil Steril ; 116(1): 4-12, 2021 07.
Artigo em Inglês | MEDLINE | ID: mdl-34148588

RESUMO

The aim of this article is to gather 9 thought leaders and their team members to present their ideas about the future of in vitro fertilization and the andrology laboratory. Although we have seen much progress and innovation in the laboratory over the years, there is still much to come, and this article looks at what these leaders think will be important in the future development of technology and processes in the laboratory.


Assuntos
Andrologia/tendências , Serviços de Laboratório Clínico/tendências , Fertilização in vitro/tendências , Infertilidade/terapia , Medicina Reprodutiva/tendências , Andrologia/legislação & jurisprudência , Automação Laboratorial , Serviços de Laboratório Clínico/legislação & jurisprudência , Difusão de Inovações , Feminino , Fertilização in vitro/legislação & jurisprudência , Previsões , História do Século XXI , Humanos , Infertilidade/diagnóstico , Infertilidade/fisiopatologia , Masculino , Formulação de Políticas , Gravidez , Medicina Reprodutiva/legislação & jurisprudência
5.
Arch Pathol Lab Med ; 145(7): 821-824, 2021 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-33765119

RESUMO

CONTEXT.­: Coronavirus disease 2019 (COVID-19) changed the dynamics of health care delivery, shifting patient priorities and deferring care perceived as less urgent. Delayed or eliminated care may place patients at risk for adverse outcomes. OBJECTIVE.­: To identify opportunities for laboratory test stewardship to close potential gaps in care created by the COVID-19 pandemic. DESIGN.­: The study was a retrospective time series design examining laboratory services received before and during the COVID-19 pandemic at a large metropolitan health system serving women and children. RESULTS.­: Laboratory test volumes displayed 3 distinct patterns: (1) a decrease during state lockdown, followed by near-complete or complete recovery; (2) no change; and (3) a persistent decrease. Tests that diagnose or monitor chronic illness recovered only partially. For example, hemoglobin A1c initially declined 80% (from 2232 for April 2019 to 452 for April 2020), and there was a sustained 16% drop (28-day daily average 117 at August 30, 2019, to 98 at August 30, 2020) 4 months later. Blood lead dropped 39% (from 2158 for April 2019 to 1314 for April 2020) and remained 23% lower after 4 months. CONCLUSIONS.­: The pandemic has taken a toll on patients, practitioners, and health systems. Laboratory professionals have access to data that can provide insight into clinical practice and identify pandemic-related gaps in care. During the pandemic, the biggest patient threat is underuse, particularly among tests to manage chronic diseases and for traditionally underserved communities and people of color. A laboratory stewardship program, focused on peri-pandemic care, positions pathologists and other laboratory professionals as health care leaders with a commitment to appropriate, equitable, and efficient care.


Assuntos
COVID-19/prevenção & controle , Serviços de Laboratório Clínico/tendências , Testes Diagnósticos de Rotina/tendências , Alocação de Recursos para a Atenção à Saúde/tendências , Acessibilidade aos Serviços de Saúde/tendências , COVID-19/diagnóstico , Serviços de Laboratório Clínico/organização & administração , Alocação de Recursos para a Atenção à Saúde/organização & administração , Política de Saúde , Acessibilidade aos Serviços de Saúde/organização & administração , Humanos , Estudos Retrospectivos , Texas
7.
ESMO Open ; 6(1): 100024, 2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-33399086

RESUMO

BACKGROUND: This study evaluated the consequences in Europe of the COVID-19 outbreak on pathology laboratories orientated toward the diagnosis of thoracic diseases. MATERIALS AND METHODS: A survey was sent to 71 pathology laboratories from 21 European countries. The questionnaire requested information concerning the organization of biosafety, the clinical and molecular pathology, the biobanking, the workload, the associated research into COVID-19, and the organization of education and training during the COVID-19 crisis, from 15 March to 31 May 2020, compared with the same period in 2019. RESULTS: Questionnaires were returned from 53/71 (75%) laboratories from 18 European countries. The biosafety procedures were heterogeneous. The workload in clinical and molecular pathology decreased dramatically by 31% (range, 3%-55%) and 26% (range, 7%-62%), respectively. According to the professional category, between 28% and 41% of the staff members were not present in the laboratories but did teleworking. A total of 70% of the laboratories developed virtual meetings for the training of residents and junior pathologists. During the period of study, none of the staff members with confirmed COVID-19 became infected as a result of handling samples. CONCLUSIONS: The COVID-19 pandemic has had a strong impact on most of the European pathology laboratories included in this study. Urgent implementation of several changes to the organization of most of these laboratories, notably to better harmonize biosafety procedures, was noted at the onset of the pandemic and maintained in the event of a new wave of infection occurring in Europe.


Assuntos
COVID-19/prevenção & controle , Serviços de Laboratório Clínico/estatística & dados numéricos , Patologia Clínica/estatística & dados numéricos , Patologia Molecular/estatística & dados numéricos , Inquéritos e Questionários , Doenças Torácicas/diagnóstico , Bancos de Espécimes Biológicos/organização & administração , Bancos de Espécimes Biológicos/estatística & dados numéricos , COVID-19/epidemiologia , COVID-19/virologia , Serviços de Laboratório Clínico/tendências , Contenção de Riscos Biológicos/estatística & dados numéricos , Surtos de Doenças , Europa (Continente)/epidemiologia , Previsões , Humanos , Pandemias , Patologia Clínica/métodos , Patologia Clínica/tendências , Patologia Molecular/métodos , Patologia Molecular/tendências , SARS-CoV-2/isolamento & purificação , SARS-CoV-2/fisiologia , Manejo de Espécimes/métodos , Manejo de Espécimes/estatística & dados numéricos , Doenças Torácicas/terapia
8.
Euro Surveill ; 25(47)2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-33243354

RESUMO

We present preliminary results of a coronavirus disease (COVID-19) impact assessment on testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region. We analyse 98 responses from secondary care (n = 36), community testing sites (n = 52) and national level (n = 10). Compared to pre-COVID-19, 95% of respondents report decreased testing volumes during March-May and 58% during June-August 2020. Reasons for decreases and mitigation measures were analysed.


Assuntos
Serviços de Laboratório Clínico/estatística & dados numéricos , Infecções por Coronavirus , Coronavirus , Atenção à Saúde/estatística & dados numéricos , Avaliação do Impacto na Saúde , Programas de Rastreamento/estatística & dados numéricos , COVID-19 , Serviços de Laboratório Clínico/tendências , Atenção à Saúde/tendências , Europa (Continente) , Infecções por HIV/diagnóstico , Hepatite C/diagnóstico , Hepatite Viral Humana/diagnóstico , Humanos , Masculino , Programas de Rastreamento/tendências , Pandemias , SARS-CoV-2 , Organização Mundial da Saúde
10.
Clin Biochem ; 84: 21-30, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32652094

RESUMO

With the recent developments in information technology, real world big data studies (RWBDSs) have attracted increasing attention in the field of medicine. In RWBDSs, clinical laboratory data is an important part of the wider scope of real-world medical data, and its standardized use is critical for the generation of high-quality real-world evidence. To improve the core functioning and competitiveness of clinical laboratories as well as provide high-quality medical services for patients, it is important to construct an information analysis model and perform RWBDSs. However, among the majority of developing countries, as well as in some developed countries, due to the poorly developed neglect of data formatting standards information construction and the lack of consideration for, and experience with, the ideas and methods of RWBDSs, many clinical laboratories are unable to make use of the vast amount of data stored in their systems. Additionally, in the literature, there remain many areas that require improvements, such as the correct misuse of research methods, appropriate unreasonable data presentation methods, and optimal opaque methods for data cleaning, storage, and mining. In this review, we describe both the advantages and disadvantages of RWBDSs in laboratory medicine. In addition, we summarize the current application and methods of RWBDS in laboratory medicine from seven different perspectives: the establishment of a reference interval, patient data-based real time quality control, diagnostic or prognostic modeling, epidemiological investigation, laboratory management, analysis of sources of variations for analytes, and external quality assessment. Finally, we discuss the future prospects of this research. This review can provide the basis for clinical laboratories to carry out real world research; additionally, it promotes and standardizes RWBDS in laboratory medicine.


Assuntos
Serviços de Laboratório Clínico/tendências , Mineração de Dados/métodos , Laboratórios/tendências , Big Data , Humanos , Controle de Qualidade , Valores de Referência , Projetos de Pesquisa , Relatório de Pesquisa
11.
Clin Lab ; 66(6)2020 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-32538066

RESUMO

BACKGROUND: About forty-five years ago the advent of Sanger sequencing (Sanger and Coulson 1975) was revolutionary as it allowed deciphering of complete genome sequences. A second revolution came when next-generation sequencing (NGS) technologies accelerated and cheapened genome sequencing. Recently, third generation/longread sequencing methods have appeared, which can directly detect epigenetic modifications on native DNA and allow whole-transcript sequencing without the need for assembly. Nanopore sequencing is one of these third-generation approaches, enabling a single molecule of DNA or RNA to be sequenced in real-time without the need for PCR amplification or chemical labelling of the sample. It works by monitoring changes to an electrical current as nucleic acids are passed through protein or synthetic nanopores. METHODS: A literature search was performed in order to collect and summarize current information about the methodological aspects of nanopore sequencing as well as some application examples. RESULTS: The review describes concisely and comprehensibly the technical aspects of nanopore sequencing and stresses the advantages and disadvantages of this technique thereby also giving examples of their potential applications in the clinical routine laboratory as are rapid identification of viral pathogens, monitoring Ebola, environmental and food safety monitoring, human and plant genome sequencing, monitoring of antibiotic resistance, and other applications. CONCLUSIONS: It is a useful incitation for such ones being permanently in search of upgrading their laboratory.


Assuntos
Sequenciamento por Nanoporos/métodos , Serviços de Laboratório Clínico/tendências , Testes Diagnósticos de Rotina , Humanos , Análise de Sequência/instrumentação , Análise de Sequência/métodos , Análise de Sequência/tendências
12.
Clin Chem Lab Med ; 58(7): 1037-1052, 2020 06 25.
Artigo em Inglês | MEDLINE | ID: mdl-32459192

RESUMO

The global coronavirus disease 2019 (COVID-19) has presented major challenges for clinical laboratories, from initial diagnosis to patient monitoring and treatment. Initial response to this pandemic involved the development, production, and distribution of diagnostic molecular assays at an unprecedented rate, leading to minimal validation requirements and concerns regarding their diagnostic accuracy in clinical settings. In addition to molecular testing, serological assays to detect antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are now becoming available from numerous diagnostic manufacturers. In both cases, the lack of peer-reviewed data and regulatory oversight, combined with general misconceptions regarding their appropriate use, have highlighted the importance of laboratory professionals in robustly validating and evaluating these assays for appropriate clinical use. The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Task Force on COVID-19 has been established to synthesize up-to-date information on the epidemiology, pathogenesis, and laboratory diagnosis and monitoring of COVID-19, as well as to develop practical recommendations on the use of molecular, serological, and biochemical tests in disease diagnosis and management. This review summarizes the latest evidence and status of molecular, serological, and biochemical testing in COVID-19 and highlights some key considerations for clinical laboratories operating to support the global fight against this ongoing pandemic. Confidently this consolidated information provides a useful resource to laboratories and a reminder of the laboratory's critical role as the world battles this unprecedented crisis.


Assuntos
Técnicas de Laboratório Clínico/métodos , Infecções por Coronavirus/diagnóstico , Pneumonia Viral/diagnóstico , Betacoronavirus/patogenicidade , Biomarcadores , COVID-19 , Serviços de Laboratório Clínico/tendências , Coronavirus/patogenicidade , Humanos , Laboratórios/tendências , Pandemias , SARS-CoV-2 , Sensibilidade e Especificidade
13.
J Am Soc Cytopathol ; 9(3): 202-211, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32284276

RESUMO

The coronavirus disease 2019 (COVID-19) is a pandemic caused by the SARS-CoV-2 virus. The infection has predominantly respiratory transmission and is transmitted through large droplets or aerosols, and less commonly by contact with infected surfaces or fomites. The alarming spread of the infection and the severe clinical disease that it may cause have led to the widespread institution of social distancing measures. Because of repeated exposure to potentially infectious patients and specimens, health care and laboratory personnel are particularly susceptible to contract COVID-19. This review paper provides an assessment of the current state of knowledge about the disease and its pathology, and the potential presence of the virus in cytology specimens. It also discusses the measures that cytology laboratories can take to function during the pandemic, and minimize the risk to their personnel, trainees, and pathologists. In addition, it explores potential means to continue to educate trainees during the COVID-19 pandemic.


Assuntos
Biologia Celular/tendências , Serviços de Laboratório Clínico/normas , Infecções por Coronavirus/patologia , Infecções por Coronavirus/prevenção & controle , Pandemias/prevenção & controle , Pneumonia Viral/patologia , Pneumonia Viral/prevenção & controle , Manejo de Espécimes/normas , Betacoronavirus/patogenicidade , COVID-19 , Serviços de Laboratório Clínico/tendências , Contenção de Riscos Biológicos/normas , Infecções por Coronavirus/transmissão , Infecções por Coronavirus/virologia , Humanos , Pneumonia Viral/transmissão , Pneumonia Viral/virologia , SARS-CoV-2 , Segurança , Manejo de Espécimes/tendências
14.
S Afr Med J ; 110(12): 1201-1205, 2020 11 05.
Artigo em Inglês | MEDLINE | ID: mdl-33403966

RESUMO

BACKGROUND: Globally, few studies have examined the effect of the COVID-19 pandemic on routine patient care and follow-up. OBJECTIVES: To evaluate the effect of the COVID-19 response on biochemical test requests received from outpatient departments (OPDs) and peripheral clinics serviced by the National Health Laboratory Service Chemical Pathology Laboratory at Tygerberg Hospital, Cape Town, South Africa (SA). Request volumes were used as a measure of the routine care of patients, as clinical information was not readily available. METHODS: A retrospective audit was conducted. The numbers of requests received from OPDs and peripheral clinics for creatinine, glycated haemoglobin (HbA1c), lipid profiles, thyroid-stimulating hormone (TSH), free thyroxine, free tri-iodothyronine (fT3), serum and urine protein electrophoresis, serum free light chains and neonatal total serum bilirubin were obtained from 1 March to 30 June for 2017, 2018, 2019 and 2020. RESULTS: The biggest impact was seen on lipids, creatinine, HbA1c, TSH and fT3. The percentage reduction between 1 March and 30 June 2019 and between 1 March and 30 June 2020 was 59% for lipids, 64% for creatinine and HbA1c, 80% for TSH and 81% for fT3. There was a noteworthy decrease in overall analyte testing from March to April 2020, coinciding with initiation of level 5 lockdown. Although an increase in testing was observed during June 2020, the number of requests was still lower than in June 2019. CONCLUSIONS: This study, focusing on the short-term consequences of the SA response to the COVID-19 pandemic, found that routine follow-up of patients with communicable and non-communicable diseases was affected. Future studies are necessary to evaluate the long-term consequences of the pandemic for these patient groups.


Assuntos
COVID-19 , Serviços de Laboratório Clínico/tendências , Técnicas de Laboratório Clínico/tendências , Atenção à Saúde , Assistência Ambulatorial , Bilirrubina/sangue , Análise Química do Sangue/tendências , Eletroforese das Proteínas Sanguíneas , Creatinina/sangue , Eletroforese/tendências , Hemoglobinas Glicadas/metabolismo , Humanos , Lipídeos/sangue , Estudos Retrospectivos , SARS-CoV-2 , Testes de Função Tireóidea/estatística & dados numéricos , Tireotropina/sangue , Tiroxina/sangue , Tri-Iodotironina/sangue , Urinálise/tendências
15.
Lab Med ; 51(4): 337-344, 2020 Jul 08.
Artigo em Inglês | MEDLINE | ID: mdl-31875907

RESUMO

OBJECTIVE: To describe the perspective of grossing technology and highlight the prospective of its development in histology laboratory. METHODS: Analysis of different components of grossing technology. RESULTS: Increased requirements for a specimen's turnaround time and the advancements in modern processing equipment make the triage of workflow a significant part of a grossing person's responsibilities. The implementation of digital pathology in morphology studies practice requires standardization of fixation, the thickness of gross section, and optimal embedding orientation. To meet tomorrow's challenges, grossing technology should work on embedding automation and gross digital pathology to record gross sections corresponding the microscope slide. Specialization of grossing stations might be beneficial to the quality of processing and smooth workflow productivity. The emerging grossing technologist subspecialty requires development of a special training program. CONCLUSION: Grossing technology can contribute to new challenges in modern histology laboratory, assuring high-quality microscope slides for the pathologist's diagnosis and research evaluation.


Assuntos
Serviços de Laboratório Clínico/normas , Citodiagnóstico/métodos , Automação Laboratorial/métodos , Automação Laboratorial/normas , Serviços de Laboratório Clínico/organização & administração , Serviços de Laboratório Clínico/tendências , Citodiagnóstico/normas , Humanos , Patologia Cirúrgica/educação
17.
J Appl Lab Med ; 3(4): 617-630, 2019 01.
Artigo em Inglês | MEDLINE | ID: mdl-31639730

RESUMO

BACKGROUND: For far too long, the diagnosis of bloodstream infections has relied on time-consuming blood cultures coupled with traditional organism identification and susceptibility testing. Technologies to define the culprit in bloodstream infections have gained sophistication in recent years, notably by application of molecular methods. CONTENT: In this review, we summarize the tests available to clinical laboratories for molecular rapid identification and resistance marker detection in blood culture bottles that have flagged positive. We explore the cost-benefit ratio of such assays, covering aspects that include performance characteristics, effect on patient care, and relevance to antibiotic stewardship initiatives. SUMMARY: Rapid blood culture diagnostics represent an advance in the care of patients with bloodstream infections, particularly those infected with resistant organisms. These diagnostics are relatively easy to implement and appear to have a positive cost-benefit balance, particularly when fully incorporated into a hospital's antimicrobial stewardship program.


Assuntos
Gestão de Antimicrobianos/tendências , Bacteriemia/diagnóstico , Hemocultura/métodos , Serviços de Laboratório Clínico/tendências , Fungemia/diagnóstico , Anti-Infecciosos/farmacologia , Anti-Infecciosos/uso terapêutico , Gestão de Antimicrobianos/economia , Gestão de Antimicrobianos/métodos , Bacteriemia/tratamento farmacológico , Bacteriemia/economia , Bacteriemia/microbiologia , Bactérias/genética , Bactérias/isolamento & purificação , Proteínas de Bactérias/genética , Proteínas de Bactérias/isolamento & purificação , Hemocultura/economia , Hemocultura/tendências , Serviços de Laboratório Clínico/economia , Serviços de Laboratório Clínico/organização & administração , Análise Custo-Benefício , DNA Bacteriano/isolamento & purificação , DNA Fúngico/isolamento & purificação , Farmacorresistência Bacteriana/genética , Farmacorresistência Fúngica/genética , Proteínas Fúngicas/genética , Proteínas Fúngicas/isolamento & purificação , Fungemia/tratamento farmacológico , Fungemia/economia , Fungemia/microbiologia , Fungos/genética , Fungos/isolamento & purificação , Técnicas de Genotipagem/economia , Técnicas de Genotipagem/instrumentação , Técnicas de Genotipagem/métodos , Custos de Cuidados de Saúde , Humanos , Testes de Sensibilidade Microbiana/instrumentação , Testes de Sensibilidade Microbiana/métodos , Fatores de Tempo , Tempo para o Tratamento
18.
Clin Lab ; 65(9)2019 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-31532088

RESUMO

BACKGROUND: The results of laboratory tests play a critical role in patient management, so the clinical laboratory is obligated to report accurate results. However, the pre-analytical phase, in which human factors are mainly involved, is clearly a vulnerable part of the laboratory process. This study was conducted to investigate and analyze pre-analytical errors. The author intended to reduce these errors by some measures in order to enhance the credibility of the laboratory. METHODS: A retrospective study was conducted to identify the rates and the types and frequencies of pre-analytical errors in the laboratory and analyze them according to the departments of patients, the sections of the laboratory, and the wards of the hospital. The reasons for these errors were persistently identified and analyzed in order to make efforts to reduce the errors. The activities for quality improvement including education and training programs on the phlebotomy teams were also accomplished to reduce these errors. RESULTS: The overall rate of pre-analytical errors was 0.40%. The rate of these errors significantly decreased from 0.44% in 2017 to 0.36% in 2018. In particular, the proportion of improper volume decreased from 46.1% in 2017 to 36.4% in 2018. The most common pre-analytical error was 'improper volume' (41.5%), followed by 'undue clotting' (32.8%). These errors were overwhelmingly more common in inpatients than in outpatients. The rate of these errors was the highest in stat section (1.95%). CONCLUSIONS: Clinical laboratory should make efforts to reduce pre-analytical errors in order to report accurate and expeditious results. Reduction of these errors can be achieved through analyzing and correcting the reasons for them and education and training on the phlebotomy teams and, as a result, the credibility of the laboratory may also be enhanced.


Assuntos
Serviços de Laboratório Clínico/normas , Técnicas de Laboratório Clínico/normas , Laboratórios Hospitalares/normas , Melhoria de Qualidade/normas , Serviços de Laboratório Clínico/tendências , Técnicas de Laboratório Clínico/métodos , Humanos , Controle de Qualidade , Melhoria de Qualidade/estatística & dados numéricos , República da Coreia , Estudos Retrospectivos
19.
Lakartidningen ; 1162019 Apr 02.
Artigo em Sueco | MEDLINE | ID: mdl-31192385

RESUMO

Internal and external factors influence the future of laboratory medicine. In the coming years point of care testing and faster and cheaper methods of genome sequencing are predicted to become more important. Changes in laboratory organization and demography with an aging population will likewise impact the coming years. An increased information flow between laboratories and clinicians, where symptoms, findings and vital signs are combined with laboratory results and their change over time, has the potential of generating refined reports. Sharing of equipment between laboratory specialities as well as working in conjunction with clinicians in influencing patterns of testing through guidelines and algorithms may also aid in saving precious resources.


Assuntos
Serviços de Laboratório Clínico/tendências , Laboratórios/tendências , Pessoal de Laboratório Médico/tendências , Serviços de Laboratório Clínico/organização & administração , Aconselhamento Diretivo/tendências , Testes Genéticos/tendências , Humanos , Laboratórios/organização & administração , Papel do Médico , Testes Imediatos/tendências , Dinâmica Populacional/tendências
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...